December 17, 2014 3:06 PM ET

Pharmaceuticals

Company Overview of kaleo, Inc.

Executive Profile

Phil Lieberman M.D., FAAAAI

Member of the Scientific Advisory Board, kaleo, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background

Phil Lieberman, MD, FAAAAI is a Clinical Professor of Medicine and Pediatrics in the Departments of Internal Medicine and Pediatrics(Divisions of Allergy and Immunology) of Tennessee - College of Medicine, Memphis, Tennessee. Dr. Lieberman served as President of the American Academy of Allergy, Asthma and Immunology, and the American Association of Certified Allergists. Dr. Lieberman also served on the Board of Directors of the American Board of Allergy and Immunology. ...

Corporate Headquarters

111 Virginia Street
Richmond, Virginia 23219

United States

Phone: 804-545-6360
Fax: 804-545-6219

Board Members Memberships

There is no Board Members Memberships data available.

Education

Unknown/Other Education
Tulane University
MD
The University Of Tennessee Health Science Center

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact kaleo, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.